Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Higher sales and operating income in the wake of increased interest for fuel cells

During the fourth quarter 2018 sales for PowerCell Sweden AB (publ) increased to MSEK 28.1 compared to MSEK 15.8 for the same period last year (+78 %). Operating income for the period amounted to MSEK -11.1 compared to MSEK -17.4 for the same period last year.“The fourth quarter was a very strong quarter, reflecting the steady increase in interest in our technology and knowledge”, Per Wassén, President and CEO of PowerCell said.The English version is an in house-translation. In case of any discrepancy, the Swedish text will prevail. The fourth quarter 2018 set a new sales record for

Year End Report

Period from January to December 2018 Peptonic Medical AB (publ) org nr 556776-3064 (www.aktietorget.se,  ticker: PMED) 2018 FOURTH QUARTER (Oct-Dec) · Net sales of products KSEK 263 (0) · Gross profit KSEK 137 (0), Gross margin 52% (0%) · Incoming purchase orders KSEK 1 431 (0) · Operating loss KSEK -4,572 (-4,753)  · Loss per share SEK -0.06 (-0.11) FULL YEAR 2018 (Jan-Dec) · Net sales of products KSEK 383 (0) · Gross profit KSEK 232 (0), Gross margin 61% (0%) · Incoming purchase orders KSEK 1 551 (0) · Operating loss KSEK 14,311 (-12,962) ·

Caverion to provide technical management services for a historical property in Helsinki city centre

Caverion Corporation Press release 27 February 2019 at 9:00 a.m.  EETCaverion to provide technical management services for a historical property in Helsinki city centre  Caverion and Trevian Asset Management have signed a cooperation agreement for technical management services in a valuable property owned by BlackRock located at Erottajankatu 2 in Helsinki. Trevian Asset Management will be in charge of developing the property and leasing the premises on behalf of BlackRock. “We were aiming to find a technical management partner that has a solid track record of managing

Interim report October-December 2018.

The full Interim report is available on Brighter's website https://brighter.se. The Interim report is also attached as a pdf file to this press release. October - December 2018. · Capitalized expenditure for development work reached SEK 11,075 thousand (12,390) · Operating income amounted to SEK 11,292 thousand (13,827) · Operating result amounted to SEK -10,843 thousand (-8,175) · Result before tax amounted to SEK -13,141 thousand (-9,514). · Earnings per share, before dilution amounted to SEK -0.17 (-0.13). · Earnings per share after dilution SEK -0.17 (SEK -0.13).

BONESUPPORT HOLDING AB (publ) – Full Year Report 2018

Lund, Sweden, 08.00 CET, 27 February 2018 – BONESUPPORT HOLDING AB (publ) - listed on Nasdaq Stockholm - an emerging leader in orthobiologics for the management of bone voids, today publish the financial report for the fourth quarter and the full year 2018. POSITIVE RESULTS FROM THE CERTIFY STUDY AND CONTINUED STRONG GROWTH IN EUROPE1 OCTOBER– 31 DECEMBER 2018▪ Net sales amounted to SEK 23.1 million (27.0), a decrease of 15%. The lower turnover should be valued in the perspective of the transition to a new distribution structure in the US with sales start on October 23, 2018. The

Year-end report January-December 2018

· Profit from property management attributable to parent company shareholders amounted to SEK 3,304m (2,804), corresponding to an increase per share by 25 % to SEK 18.35 (14.74) · Rental income amounted to SEK 6,714m (5,915) · Profit after tax attributable to parent company shareholders amounted to SEK 9,308m (7,118) corresponding to SEK 51.71 per share (38.71) · Long term net asset value amounted to SEK 280.17 per share (229.25) and shareholders' equity (including listed associated companies at market value) amounted to SEK 225.60 per share (185.02)  Profit from

Flexion Mobile Plc - Q3 Report 31 December 2018

Flexion continues to grow its Q3 revenue. Total revenue increase to GBP 1.3m and its core business grows by 232%. During the quarter several large transactions were closed including the biggest deal in the Company’s history with an expected order value in excess of GBP 4m over time. In total, 7 titles were signed. The company also announced a strategic partnership with Samsung which increases visibility within the gaming community.October to December performance · IAP (In App Purchase) revenue increased by 232% to GBP 1.2m (GBP 0.4m*) · Total revenue increased by 154% to GBP 1.3m (

Heroes & Superstars running on GINX Esports TV

Nitro Games announced the reality show Heroes & Superstars is now running on Ginx.TV linear television globally. The reality show Heroes & Superstars is now shown globally in linear television. GINX Esports TV has the exclusive rights for linear TV in France, UK, Canada and South Africa. All other territories are non-exclusive. The show is broadcasted on Sundays, with a new episode each week. There’s a total of 6 episodes in the show, and the show is expected to run 5 times in 2019. GINX Esports TV is the first and largest esports TV network. Available in 55+ million homes,

Telefónica and Ericsson sign AI-powered Network Operations agreement

· Managed services deal includes AI-powered Network Operations in UK, Colombia, Peru, Ecuador and Uruguay · Supports and reinforces Telefónica’s strategy for evolved network management based on AI and automation · Telefónica customers across five countries to benefit from best-in-class network performance powered by Ericsson’s global scale, processes, and AI and automation solutionsEricsson (NASDAQ: ERIC) and Telefónica, one of the world’s largest communications service providers, have penned a new four-to-six-year managed services deal for AI-powered Network Operations in the UK,

Interim report for BEWiSynbra Group for the period January to December 2018

Highlights from the report Numbers in parentheses refers to the corresponding period in the previous year. Fourth quarter 2018 · BEWiSynbra Group reported net sales of SEK 1,220 million (SEK 528 million), an increase of 131 per cent since the same period of 2017 of which 146 percentage points (pp) was explained by acquisitions · Adjusted EBITDA was SEK 101 million for the fourth quarter of 2018 (SEK 32 million)  · The earnings were negatively impacted by items affecting comparability of SEK 20 million for the quarter, mainly related to the planned IPO and transactions ·

FINANCIAL DEVELOPMENT IN LINE WITH GUIDANCE

NOVEMBER 2018–JANUARY 2019 · Revenue: MSEK 9,534 (8,978) · Earnings before tax and nonrecurring items: MSEK -724 (-385) · EBT: MSEK -576 (-285) · Net income for the period: MSEK -469 (-249) · Earnings per common share: SEK -1.25 (-0.88) COMMENTS BY THE CEO In the face of challenges, SAS is continuing its transition towards a viable and sustainable future. FOR FURTHER INFORMATION, PLEASE CONTACT: Michel Fischier, VP Investor Relations, +46 70 997 0673 This information is information that SAS AB is obliged to disclose pursuant to the EU Market Abuse Regulation.

Isofol Medical AB (publ) appoints Carnegie Investment Bank AB (publ) to Financial advisor

GOTHENBURG, Sweden, February 27, 2019 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), announced today that the company and the board have appointed Carnegie Investment Bank AB (publ) as financial advisor to explore a possible listing of the company's shares at Nasdaq Stockholm main market within 12-18 months and to evaluate other strategic and financial initiatives together with Pareto Securities AB.For further information, please contact: Isofol Medical AB (publ)Anders Rabbe, CEOE­-mail: info@isofolmedical.comPhone: +46 (0)707 646 500 Gustaf Albert, CFOE­-

Notice convening the Annual General Meeting of Vestas Wind Systems A/S

 Vestas Wind Systems A/S, Aarhus, 27 February 2019 To the shareholders of Vestas Wind Systems A/S Pursuant to article 4 of the Articles of association, you are hereby convened for the Annual General Meeting of Vestas Wind Systems A/S (Company Reg. No. 10403782) on Wednesday, 3 April 2019 at 2:00 pm (CEST) at the Concert Hall Aarhus (Musikhuset Aarhus), Thomas Jensens Allé, 8000 Aarhus C, Denmark.

Sweco expands the road network in Poland and improves safety

Sweco has been commissioned to design a total of 40 km of new road sections in Poland. The total order value is SEK 64 million.Sweco, in consortia with local business partners, has been commissioned for planning and design of an 18 km section of the S7 expressway, between the Widoma junction and Krakow. One of the engineering challenges includes changing the course of the Dłubnia river and the Baranówka stream that flow through the planned route. There are also buildings of significant historical value in connection with the route that need to be taken into consideration. In Lower

Read original

Archer Limited: Fourth Quarter 2018 Earnings Release

Hamilton, Bermuda (February 27, 2019) Fourth quarter highlights 2018 - Best operational results since 2015 ·  Revenue of $233.2 million, an increase of 9% from third quarter.  ·  EBITDA before exceptional items of $26.9 million, an increase of $10.4 million or 63% relative to Q4 2017.  ·  EBITDA of $24.3 million, an increase of $9.6 million or 65% relative to Q4 2017.  ·  EBIT of $10.7 million or 4.6% of revenue.  ·  Net Interest Bearing Debt reduced to $585.8 million. John Lechner, CEO Archer comments: “Archer is pleased to deliver the strongest quarterly

Nordic Nanovector ASA: Resultater for fjerde kvartal og helår 2018

Oslo, 27. februar 2019 Nordic Nanovector ASA (OSE: NANO) publiserer i dag sine resultater for fjerde kvartal og helår 2018. Selskapets ledelse vil gi en presentasjon av resultatene klokken 08:30 på Thon Hotel Vika Atrium i Oslo. Se ytterligere informasjon nedenfor. - Vi har sett god fremgang i 2018 for de viktige kliniske utviklingsprogrammene for Betalutin®, både som eneste behandling og i kombinasjon med rituximab hos pasienter med non-Hodgkins lymfom. Resultatene fra LYMRIT 37-01-studien, som ble presentert på ASH-konferansen i desember, bekrefter nok en gang den sterke kliniske

Höegh LNG : Key information relating to the cash dividend to be paid by Höegh LNG Holdings Ltd.

Hamilton, Bermuda, 27 February 2019 - Key information relating to the cash dividend to be paid by Höegh LNG Holdings Ltd. Amount: USD 0.025 per shareDeclared currency: United States DollarLast day including right: 5 March 2019Ex-date: 6 March 2019Record date: 7 March 2019Payment date: On or about 21 March 2019Date of approval: 26 February 2019  * * * About Höegh LNG: Höegh LNG operates world-wide with a leading position as owner and operator of floating LNG import terminals; floating storage and regasification units (FSRUs), and is one of the most experienced

Höegh LNG : Interim results for the quarter and year ended 31 December 2018

Hamilton, Bermuda, 27 February 2019 - Höegh LNG Holdings Ltd. ("Höegh LNG") today reports its financial results for the quarter and year ended 31 December 2018 Highlights for the fourth quarter of 2018:  · EBITDA of USD 81.4 million, including USD 34.7 million in recognition of remaining payments from Egas under the amended contract structure for Höegh Gallant · Net profit of USD 45.0 million · Dividend of USD 0.025 per share paid in the fourth quarter of 2018 · Investment in Avenir LNG to pursue small-scale LNG market · Höegh Gannet delivered on interim time charter to

Insr: Q4 and Preliminary 2018 results: Set for profit in 2019. Standal appointed Deputy CEO

Oslo, February 27th, 2019 Insr Insurance Group ASA (OSE:INSR) announces results for the fourth quarter of 2018 and preliminary full year results. A presentation of the results by the Group’s senior management will take place today at 08:30 CET - see details below. Fourth quarter 2018 Net result for the quarter, including other comprehensive income, was a loss of NOK 13.9 million (pro forma loss of NOK 173.5 million in Q4 2017). Gross combined ratio was 111.1% (151.0%). Net combined ratio was somewhat lower than the gross ratio at 109.1% (246.0%). Net loss ratio was below

Photocure ASA: Results for the fourth quarter of 2018

Oslo, Norway, 27 February 2019: Photocure ASA (OSE:PHO), today reported a revenue growth of 76% in local currency for the U.S. market in the fourth quarter of 2018, contributing to Hexvix/Cysview revenues of NOK 46.3 million (Q4 2017: NOK 39.4) and a recurring EBITDA of NOK -4.1 million (NOK -13.1 million). The company maintains its 2020 forecasted revenue range of USD 20-25 million in the U.S., up from USD 7.8 million in 2018, and sees significant continued revenue growth and profit opportunities in the U.S. market beyond 2020.“We closed 2018 with an acceleration in forward momentum

NEXT Biometrics Group ASA – Interim report as at 31 December 2018

HIGHLIGHTS Q4-2018 * Q4-18 revenue of NOK 29.3 million, compared with NOK 30.2 million in Q3-18 * Q4-18 gross margin of 36%, compared with 30% in Q3-18 * Full-year 2018 revenue growth of 10% and gross margin of 28% (FY 2017: -6%) * Sampling of One Touch ID FAP 20 sensor started in Q4-18 * Infineon technology partnership and R&D program with MK Group strengthen smart card position * Government ID progress with orders from Telpo, Tysso and India agreement with Digitsecure Post Q4-18 events * Received and delivered purchase order for 30,000 chipsets from Tactilis *

Nel ASA: Fourth Quarter 2018 Results

(Oslo, February 27, 2019) Nel ASA (“Nel”) reported revenues in the fourth quarter of 2018 of NOK 124.9 million, up from NOK 115.6 million in the fourth quarter of 2017, representing a growth of 8%. The figures are in line with the guidance and trading update provided in connection with the announcement regarding the contemplated private placement on January 30, 2019. Nel received several purchase orders during the quarter, has an all-time high pipeline and reiterates its strong market outlook. “The fourth quarter reflects Nel’s focus on staying at the technological forefront across

Nordic Nanovector ASA - Results for the Fourth Quarter and Full Year 2018

Oslo, Norway, 27 February 2019 Nordic Nanovector ASA (OSE: NANO) announces its results for the fourth quarter and full year 2018. A presentation by the company’s senior management team will take place today in Oslo at 08:30 CET, see details below. Eduardo Bravo, CEO, commented: “We believe we have made solid progress during 2018 advancing the key clinical development programmes for Betalutin® as a single agent and in combination with rituximab in non-Hodgkin’s lymphoma patients. The latest results from the LYMRIT 37-01 trial, presented at ASH in December, continue to highlight

Neste Capital Markets Day 2019: Sustainable high-margin growth and cash generation

Neste Corporation Press Release 27 February at 7 am. (EET) Neste is holding a Capital Markets Day 2019 in London today, 27 February, featuring presentations by President and CEO Peter Vanacker and CFO Jyrki Mäki-Kala on the company strategy, market outlook and the next steps for creating sustainable high-margin growth and cash generation. Renewed long-term strategy Neste targets to become a global leader in renewable and circular solutions. The renewed long-term strategy is designed to move Neste faster and bolder to realize its sustainability aspirations while growing

There are no items matching the current filter
There are no more items matching the current filter
Back to top